169 related articles for article (PubMed ID: 16903927)
1. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary.
Semjén D; Dénes B; Somorácz Á; Fintha A; Forika G; Jenei A; Dobi D; Micsik T; Eizler KV; Giba N; Sánta F; Sejben A; Iványi B; Kuthi L
Pathobiology; 2023; 90(5):322-332. PubMed ID: 36696889
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Ishihara H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Nagashima Y; Kondo T; Takagi T
Int J Urol; 2024 Jan; 31(1):73-81. PubMed ID: 37798866
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography.
Rossi SH; Hsu R; Blick C; Goh V; Nathan P; Nicol D; Fleming S; Sweeting M; Wilson EC; Stewart GD
Br J Surg; 2017 May; 104(6):648-659. PubMed ID: 28407225
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma.
Cairns P
Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
[TBL] [Abstract][Full Text] [Related]
6. Heterotopic bone formation in a case of clear cell renal cell carcinoma: A case report.
Bavikar R; Patel P; Verma A; Ingale Y; Randive R
J Cancer Res Ther; 2024 Jan; 20(1):482-484. PubMed ID: 38554371
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and screening for renal cancer.
Rossi SH; Klatte T; Usher-Smith J; Stewart GD
World J Urol; 2018 Sep; 36(9):1341-1353. PubMed ID: 29610964
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease.
Bekku K; Nagasaki N; Tsuboi I; Takamoto A; Katayama S; Araki M
Int J Urol; 2023 Oct; 30(10):931-933. PubMed ID: 37278602
[No Abstract] [Full Text] [Related]
9. Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report.
Zhou L; Xu H; Liu Y; Li X; Li C; Yang X; Wang C
Front Oncol; 2024; 14():1349610. PubMed ID: 38371617
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care.
Corcoran AT; Smaldone MC; Egleston BL; Simhan J; Ginzburg S; Morgan TM; Walton J; Chen DY; Viterbo R; Greenberg RE; Uzzo RG; Kutikov A
BJU Int; 2013 Jul; 112(2):161-8. PubMed ID: 23795784
[TBL] [Abstract][Full Text] [Related]
11. Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Duong NX; Le MK; Nguyen TT; Nguyen DD; Vuong HG; Kondo T; Mitsui T
Clin Genitourin Cancer; 2024 Feb; 22(3):102050. PubMed ID: 38502982
[TBL] [Abstract][Full Text] [Related]
12. Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes.
Campi R; Rebez G; Klatte T; Roussel E; Ouizad I; Ingels A; Pavan N; Kara O; Erdem S; Bertolo R; Capitanio U; Mir MC
Nat Rev Urol; 2023 Nov; 20(11):669-681. PubMed ID: 37328546
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Renal Cell Carcinoma.
Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
[TBL] [Abstract][Full Text] [Related]
14. Current evidence on screening for renal cancer.
Usher-Smith J; Simmons RK; Rossi SH; Stewart GD
Nat Rev Urol; 2020 Nov; 17(11):637-642. PubMed ID: 32860009
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a mixed-method study to assess chronic cough in patients with renal cell carcinoma: the prevalence, impact on quality of life, trigger and potential clinical application of chronic cough as an early screening tool in patients with kidney cancer.
Smith W; Loizidou M; Mazzone S; Mumtaz F; Gurusamy K; Ranieri V; Tran MG
BMJ Open; 2023 Nov; 13(11):e074077. PubMed ID: 37949629
[TBL] [Abstract][Full Text] [Related]
16. Editorial Comment on "Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease".
Kandori S
Int J Urol; 2023 Oct; 30(10):933. PubMed ID: 37431801
[No Abstract] [Full Text] [Related]
17. Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.
Singleton RK; Heath AK; Clasen JL; Scelo G; Johansson M; Calvez-Kelm FL; Weiderpass E; Liedberg F; Ljungberg B; Harbs J; Olsen A; Tjønneland A; Dahm CC; Kaaks R; Fortner RT; Panico S; Tagliabue G; Masala G; Tumino R; Ricceri F; Gram IT; Santiuste C; Bonet C; Rodriguez-Barranco M; Schulze MB; Bergmann MM; Travis RC; Tzoulaki I; Riboli E; Muller DC
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):507-512. PubMed ID: 33335022
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: links and risks.
Kabaria R; Klaassen Z; Terris MK
Int J Nephrol Renovasc Dis; 2016; 9():45-52. PubMed ID: 27022296
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in dialysis patients.
Sasagawa I; Nakada T; Kubota Y; Suzuki Y; Ishigooka M; Terasawa Y
Urol Int; 1994; 53(2):79-81. PubMed ID: 7801421
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma in patients with end-stage renal disease: a comparison of clinical significance in patients receiving hemodialysis and those with renal transplants.
Pope JC; Koch MO; Bluth RF
Urology; 1994 Oct; 44(4):497-501. PubMed ID: 7941189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
